Community Is ‘One of the Biggest Assets’ for Patients With MPNs

News
Video

An expert explained the benefits of patients with myeloproliferative neoplasms finding a community of people with similar diagnoses.

Patients with myeloproliferative neoplasms (MPNs) can find immense benefit from joining a community of people with a similar diagnosis, according to Nichole Ard, senior clinical studies coordinator at The University of Texas MD Anderson Cancer Center in Houston.

MPNs are a group of rare blood disorders that affect the way that the bone marrow makes blood. MPN groups help patients connect, review resources and become more educated on their disease, according to Ard, who was also honored at CURE®’s 11th annual MPN Heroes® recognition event.

READ MORE:LeVar Burton Gives ‘Voice and Visibility’ to Patients with MPNs Through Storytelling and Advocacy

“I have patients that come in and they already know what I'm going to say half the time because they've talked to somebody else who's told them their story,” Ard said in an interview with CURE® ahead of the event.

Transcript

With my work, I've found that MPN patients find a community. There is a large community of patients that have gotten together, and they talk, and they review resources, and they tell their stories to each other, and I feel like that is probably one of the biggest assets for that community is that they are able to do those things.

I have patients that come in and they already know what I'm going to say half the time because they've talked to somebody else who's told them their story. And so I think that's a big part of any cancer is finding community, finding somebody who can relate with you in, in what you're going through. And I've, I've just found that that's been super helpful for my patients.


For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
A man with a dark gray button-up shirt with glasses and cropped brown hair.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Dr. Nguyen, from Stanford Health, in an interview with CURE
Dr. Barzi in an interview with CURE
Sue Friedman in an interview with CURE